Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus

Updated 06/21/2024

Status Terminated

Clinical Trial Summary

The primary objective of this study is to evaluate the safety and tolerability of edecesertib (formerly GS-5718) in participants with cutaneous lupus erythematosus (CLE) with or without systemic lupus erythematosus (SLE).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04809623
Study type	Interventional
Source	Gilead Sciences
Contact
Status	Terminated
Phase	Phase 1
Start date	September 1, 2021
Completion date	October 18, 2022

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01776190` - Low-dose UVA1 Radiation in Cutaneous Lupus Patients	N/A
	Completed	`NCT00420173` - Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)	N/A
	Completed	`NCT01300208` - To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus	Phase 2
	Terminated	`NCT01470313` - A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus	Phase 1
	Completed	`NCT01146444` - Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)	N/A
	Completed	`NCT03134222` - Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)	Phase 2
	Completed	`NCT01629784` - Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus	N/A
	Completed	`NCT00470912` - Sunscreen RV 2457C in Photoinduced CLE	Phase 3
	Completed	`NCT01841619` - IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus	Phase 0
	Completed	`NCT00523588` - Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser	Phase 2
	Recruiting	`NCT06411106` - Deep Phenotyping of Cutaneous Lupus Erythematosus	N/A
	Not yet recruiting	`NCT06015737` - A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus	Phase 3
	Terminated	`NCT01498406` - Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus	Phase 2
	Completed	`NCT04647708` - Study of M5049 in CLE and SLE Participants	Phase 1
	Completed	`NCT03817424` - A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis	Phase 1
	Active, not recruiting	`NCT03260166` - Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus	Phase 2
	Completed	`NCT00317681` - Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)	Phase 2
	Completed	`NCT04781816` - Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus	Phase 2